The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of UGT1A’s polymorphisms and RAS: RAF mutations based on phase II study of biweekly XELIRI plus bevacizumab as a second-line therapy in patients with metastatic colorectal cancer.
 
Hiroaki Tanioka
No Relationships to Disclose
 
Nobuaki Suzuki
No Relationships to Disclose
 
Shoichi Hazama
Research Funding - NEC Corporation of America; Toyo Kohan Co., Ltd.
 
Takeshi Nagasaka
No Relationships to Disclose
 
Yasuo Iwamoto
No Relationships to Disclose
 
Yuji Negoro
No Relationships to Disclose
 
Yuki Nakagami
No Relationships to Disclose
 
Ryouichi Tsunedomi
No Relationships to Disclose
 
Hiroaki Nagano
No Relationships to Disclose
 
Masazumi Okajima
No Relationships to Disclose